|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$4.32 |
$4.42 |
$4.28 |
$4.28 |
10.40K | 04/18/2024 |
$4.49 |
$5.00 |
$4.41 |
$4.52 |
49.60K | 04/19/2024 |
$4.59 |
$4.66 |
$4.40 |
$4.65 |
10.60K | 04/22/2024 |
$4.78 |
$4.78 |
$4.30 |
$4.30 |
16.80K | 04/23/2024 |
$4.29 |
$4.60 |
$4.29 |
$4.60 |
7.40K |
|
Moleculin Biotech is a clinical stage pharmaceutical company. Co.'s technologies include: Annamycin, an anthracycline designed to be different than existing approved anthracyclines by eliminating cardiotoxicity and avoiding the multidrug resistance mechanisms; WP1066 Portfolio, which includes WP1066 and WP1220, two of several Immune/Transcription Modulators in the portfolio designed to inhibit phosphorylated signal transducer and activator of transcription among other transcription factors associated with tumor activity, while also stimulating a natural immune response to tumors by inhibiting the errant activity of Regulatory T-Cells. | |
|
Moleculin Biotech (MBRX) has the following price history information. Looking back at MBRX historical stock prices for the last five trading days, on April 17, 2024, MBRX opened at $4.32, traded as high as $4.42 and as low as $4.28, and closed at $4.28. Trading volume was a total of 10.40K shares. On April 18, 2024, MBRX opened at $4.49, traded as high as $5.00 and as low as $4.41, and closed at $4.52. Trading volume was a total of 49.60K shares. On April 19, 2024, MBRX opened at $4.59, traded as high as $4.66 and as low as $4.40, and closed at $4.65. Trading volume was a total of 10.60K shares. On April 22, 2024, MBRX opened at $4.78, traded as high as $4.78 and as low as $4.30, and closed at $4.30. Trading volume was a total of 16.80K shares. On April 23, 2024, MBRX opened at $4.29, traded as high as $4.60 and as low as $4.29, and closed at $4.60. Trading volume was a total of 7.40K shares.
MBRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Moleculin Biotech shares, starting with a $10,000 purchase of MBRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/03/2016 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$801.00 |
|
End price/share: |
$4.60 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.43% |
|
Average Annual Total Return: |
-47.99% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$57.42 |
|
Years: |
7.89 |
|
|
|
Date |
Close |
04/17/2024 | $4.28 | 04/18/2024 | $4.52 | 04/19/2024 | $4.65 | 04/22/2024 | $4.30 | 04/23/2024 | $4.60 |
|
|